COVID-19 Vaccine Development Tools Market Size Report, Industry Share, Analysis, Growth, Forecast, 2021 – 2028

COVID-19 Vaccine Development Tools Market

COVID-19 Vaccine Development Tools Market - By Technology (Lab Technologies, PCR & qPCR, Flow Cytometry, Spectrometry, Electron Microscopy, and Next Generation Sequencing), By End-Use (CROs and Pharma & BioPharma Firms), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Category: Biotechnology Report Format : PDF Pages: 160 Report Code: ZMR-6528 Published Date: Jul-2021 Status : Published
Market Size in 2020 Market Forecast in 2028 CAGR (in %) Base Year
USD 15.5 Billion USD 22.7 Billion 8.7% 2020

COVID-19 Vaccine Development Tools Market

COVID-19 Vaccine Development Tools Industry Prospective:

The global COVID-19 Vaccine Development Tools market size accrued earnings worth approximately 15.5 (USD Billion) in 2020 and is predicted to gain revenue of about 22.7 (USD Billion) by 2028, is set to record a CAGR of nearly 8.7% over the period from 2021 to 2028.

The report offers an assessment and analysis of the COVID-19 Vaccine Development Tools market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

COVID-19 Vaccine Development Tools Market: Outlook

The development of vaccines for COVID-19 is key for the global economy to return to normalcy and hence various efforts & investments have been made by many countries for developing vaccines for offering protection to individuals against the SARS-CoV-2 virus.

According to NCBI, till March 2021, nearly 13 vaccines were approved for use and nearly more than 90 vaccines were undergoing phases of clinical trials. In addition to this, artificial intelligence and machine learning have proved to be effective tools in developing COVID-19 vaccines. According to WHO, major components in vaccine development include antigens, residuals, preservatives, diluents, stabilizers, and surfactants and are manufactured by reputed pharma firms Pfizer, BioNTech, and Merck.

Furthermore, vaccine development can take many years of research before it can be approved for medical use by statutory (medical) authorities. Vaccine Inoculation for larger populations becomes possible only after the approval of vaccines. After the development of a new vaccine, it is tested in three phases. Phase I or the preclinical phase includes testing of vaccines on animals and then on a limited number of individuals to record or report stimulation of the immune system due to vaccine injection.

Phase II testing includes vaccine inoculation in many persons involving old persons & children, thereby proving the safety of vaccine inoculation in persons belonging to different age groups. The final phase includes phase III clinical trials of vaccines performed on a large percentage of the population.

Apparently, these phase III clinical studies determine the effectiveness of vaccines against coronavirus without any side effects, thereby helping researchers in determining the efficiency of vaccines. Based on the success of Phase III trials, healthcare authorities decide on providing restricted approval for vaccines. After that, state officials review the overall outcomes of clinical trials and based on that decide on fully approving the production & use of vaccines.

Global COVID-19 Vaccine Development Tools Market Request Free Sample

COVID-19 Vaccine Development Tools Market: Growth Drivers

An increase in the number of vaccine producers in both emerging economies and developed countries will boost the growth of the COVID-19 vaccine development tools market in the upcoming years. Large-scale use of AI tools in the development of the COVID-19 vaccine and a surge in strategic alliances & partnerships between various pharma firms facilitating intense research on vaccine development & production will enhance the expansion of the COVID-19 vaccine development tools industry in the foreseeable future.

Citing an instance, AstraZeneca entered into a partnership with Serum Institute in India for developing Covishield Vaccine. Another instance is of Sanofi aiding the production of the COVID-19 vaccine by combining Pfizer-BioNtech firms through the offering of services of bottle filling & packing for vaccines later. Favorable government legislation & incentives will prop up the expansion of industry in the years ahead.

Furthermore, the need for avoiding COVID-19 vaccine manufacturing delays will promulgate growth of the Covid-19 vaccine development tool market over the forthcoming years. Enormous funding of research & development activities by private firms as well as government organizations for developing effective vaccines against COVID-19 for combating the spread of the COVID-19 pandemic along with reducing its intensity & effect through enhancing human body immunity will steer market trends.

COVID-19 Vaccine Development Tools Market: Report Scope

Report Attributes Report Details
Report Name COVID-19 Vaccine Development Tools Market Research Report
Market Size in 2020 USD 15.5 Billion
Market Forecast in 2028 USD 22.7 Billion
Growth Rate CAGR of 8.7%
Number of Pages 255
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered Thermo Fisher Scientific, Inc., Pfizer Inc., Celerion, Sartorius AG, Cole-Parmer Instrument Company, LLC, STEMCELL Technologies Inc., Illumina, Inc., AB Sciex Private Limited, Agilent Technologies, Danaher Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Merck KgaA, Shimadzu Corporation, PerkinElmer Inc., Eurofins Scientific, and Aurora Biomed Inc.
Segments Covered By Technology, By End-Use, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Base Year 2020
Historical Year 2018 to 2020
Forecast Year 2021 - 2028
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

COVID-19 Vaccine Development Tools Market: Regional Landscape

Asia Pacific To Contribute Major Market Share During 2021-2028

The expansion of the COVID-19 vaccine development tools market in the Asia Pacific during the assessment period can be credited to a prominent surge in vaccine development for COVID-19 in countries such as India, Israel, and China. Furthermore, determining of new COVID genome in the initial stage through the use of modern sequencing tools by researchers of the sub-continent will expedite the business landscape in the Asia Pacific over the ensuing years. Additionally, large-scale utilization of genome sequencing tools, viral structure examination tools, and immune response profiling systems for developing new vaccines against COVID-19 will steer regional industry trends.

COVID-19 Vaccine Development Tools Market: Competitive Landscape

Key players profiled in the study include

  • Thermo Fisher Scientific. Inc.
  • Pfizer Inc.
  • Celerion, Sartorius AG
  • Cole-Parmer Instrument Company
  • LLC
  • STEMCELL Technologies Inc.
  • Illumina. Inc.
  • AB Sciex Private Limited
  • Agilent Technologies
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Qiagen N.V.
  • Merck KgaA
  • Shimadzu Corporation
  • PerkinElmer Inc.
  • Eurofins Scientific
  • Aurora Biomed Inc.

The global COVID-19 Vaccine Development Tools Market is segmented as follows:

By Technology

By End-Use

  • CROs
  • Pharma & BioPharma Firms

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Increase in number of vaccine producers in both emerging economies and developed countries will boost growth of COVID-19 vaccine development tools market in upcoming years. Large-scale use of AI tools in development of COVID-19 vaccine and surge in strategic alliances & partnerships between various pharma firms facilitating intense research on vaccine development & production will enhance expansion of COVID-19 vaccine development tools industry in foreseeable future.

According to Zion market research report, the global COVID-19 Vaccine Development Tools market accrued earnings worth approximately 15.5(USD Billion) in 2020 and is predicted to gain revenue of about 22.7(USD Billion) by 2028, is set to record a CAGR of nearly 8.7% over the period from 2021 to 2028.

Asia Pacific will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is owing to prominent surge in vaccine development for COVID-19 in countries such as India, Israel, and China. Furthermore, determining of new COVID genome in initial stage through use of modern sequencing tools by researchers of sub-continent will expedite business landscape in Asia Pacific over ensuing years. Additionally, large-scale utilization of genome sequencing tools, viral structure examination tools, and immune response profiling systems for developing new vaccines against COVID-19 will steer regional industry trends.  

The key market participants include Thermo Fisher Scientific, Inc., Pfizer Inc., Celerion, Sartorius AG,      Cole-Parmer Instrument Company, LLC, STEMCELL Technologies Inc., Illumina, Inc., AB Sciex Private Limited,  Agilent Technologies, Danaher Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Merck KgaA, Shimadzu Corporation, PerkinElmer Inc., Eurofins Scientific, and Aurora Biomed Inc.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed